Hamilton Thorne (TSE:HTL) has released an update.
Hamilton Thorne is set to be acquired by Astorg at CAD$2.25 per share, marking an enterprise value of about CAD$388 million, which is a significant premium over recent trading prices. The board of Hamilton Thorne has unanimously endorsed the deal as beneficial and financially fair to its shareholders. Astorg also plans to integrate Hamilton Thorne with Cook Medical’s ART product line post-acquisition.
For further insights into TSE:HTL stock, check out TipRanks’ Stock Analysis page.
